Complicated Community Acquired Pneumonia In Childhood: Different Types, Clinical Course, And Outcome
Ira Erlichman, O. Breuer, D. Shoseyov, M. Cohen-Cymberknoh, B. Koplewitz, D. Averbuch, Matti Erlichman, E. Picard, E. Kerem
Published 2017 · Medicine
Download PDFAnalyze on Scholarcy
The incidence of pediatric community acquired complicated pneumonia (PCACP) is increasing. Questions addressed: Are different types of PCACP one disease? How do different treatment protocols affect the outcome? METHODS Retrospective analysis of medical records of PCACP hospitalizations in the three major hospitals in Jerusalem in the years 2001-2010 for demographics, clinical presentation, management, and outcome. RESULTS Of the 144 children (51% aged 1-4 years), 91% of Jewish origin; 40% had para-pneumonic effusion (PPE), 40% empyema (EMP), and 20% necrotizing pneumonia (NP). Bacterial origin was identified in 42% (empyema 79%, P = 0.009), most common S. pneumoniae (32%), group A streptococcus (9%). Patients with EMP, compared to PPE and NP, were less likely to receive prior antibiotic treatment (35% vs. 57% and 59%, respectively, P = 0.04). Mean hospitalization was longer in patients with NP followed by EMP and PPE (16.4 ± 10.6, 15.2 ± 7.9, and 12.7 ± 4.7 days, respectively), use of fibrinolysis was not associated with the outcome. All children had recovered to discharge regardless of antibiotic therapy or fibrinolysis. ANSWER NP is a more severe disease with prolonged morbidity and hospitalization in spite of prior antibiotic treatment. All types had favorable outcome regardless of treatment-protocol. Complicated pneumonia has an ethnic predominance. Pediatr Pulmonol. 2017;52:247-254. © 2016 Wiley Periodicals, Inc.
This paper references
BTS guidelines for the management of pleural infection in children
I. Balfour-Lynn (2005)
Increase in incidence of childhood empyema.
S. Playfor (1997)
Empyema thoracis in children: a 26-year review of the Montreal Children's Hospital experience.
W. Chan (1997)
[Streptococcus pneumoniae serotypes involved in children with pleural empyemas in France].
H. Bekri (2007)
Randomized controlled trial of intrapleural streptokinase in empyema thoracis in children
M. Singh (2004)
Community-acquired pneumonia in children.
K. McIntosh (2002)
Thoracoscopic decortication vs tube thoracostomy with fibrinolysis for empyema in children: a prospective, randomized trial.
S. S. St. Peter (2009)
Comparison of urokinase and video-assisted thoracoscopic surgery for treatment of childhood empyema.
S. Sonnappa (2006)
Treatment Trends and Outcomes in US Hospital Stays of Children With Empyema
M. M. Kelly (2014)
Necrotising pneumonia is an increasingly detected complication of pneumonia in children
G. Sawicki (2008)
Etiology of community-acquired pneumonia in hospitalized children based on WHO clinical guidelines
M. Cevey-Macherel (2009)
Assessment of the burden of paediatric empyema in Australia
Roxanne E Strachan (2009)
Empyema associated with community-acquired pneumonia: A Pediatric Investigator's Collaborative Network on Infections in Canada (PICNIC) study
J. Langley (2008)
Clinical characteristics of children with complicated pneumonia caused by Streptococcus pneumoniae.
T. Tan (2002)
Cost-effectiveness of Competing Strategies for the Treatment of Pediatric Empyema
E. Cohen (2008)
Intrapleural fibrinolytic therapy for treatment of adult parapneumonic effusions and empyemas: a systematic review and meta-analysis.
S. Janda (2012)
FIVE-FOLD INCREASE IN PEDIATRIC PARAPNEUMONIC EMPYEMA SINCE INTRODUCTION OF PNEUMOCOCCAL CONJUGATE VACCINE
D. J. Hendrickson (2008)
Video-assisted thorascopic surgery vs chest drain with fibrinolytics for the treatment of pleural empyema in children: a systematic review of randomized controlled trials.
S. Mahant (2010)
CHILDHOOD EMPYEMA: LIMITED POTENTIAL IMPACT OF 7-VALENT PNEUMOCOCCAL CONJUGATE VACCINE
Margaret E Fletcher (2006)
Risk factors for the development of pleural empyema in children.
M. Elemraid (2015)
Empyema Hospitalizations Increased in US Children Despite Pneumococcal Conjugate Vaccine
S. Li (2010)
Necrotising pneumonia in children.
D. Spencer (2014)
The changing face of pleural empyemas in children: epidemiology and management.
K. D. Schultz (2004)
The Management of Community-Acquired Pneumonia in Infants and Children Older Than 3 Months of Age: Clinical Practice Guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America
J. Bradley (2011)
Complications and treatment failures of video-assisted thoracoscopic debridement for pediatric empyema
Andreas Meier (2010)
Pediatric empyema: Outcome analysis of thoracoscopic management.
J. Chen (2009)
Clinical practice: treatment of childhood empyema
M. Proesmans (2009)
Urokinase Versus VATS for Treatment of Empyema: A Randomized Multicenter Clinical Trial
C. Marhuenda (2014)
Comparison of the methods of fibrinolysis by tube thoracostomy and thoracoscopic decortication in children with stage II and III empyema: a prospective randomized study
U. Cobanoglu (2011)
Executive summary: the management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America.
J. Bradley (2011)
Thoracoscopy in the treatment of pleural empyema in pediatric patients.
Davi Wen Wei Kang (2008)
Primary operative management for pediatric empyema: decreases in hospital length of stay and charges in a national sample.
S. Li (2008)
Bacteremic necrotizing pneumococcal pneumonia in children.
E. Kerem (1994)
An epidemiological investigation of a sustained high rate of pediatric parapneumonic empyema: risk factors and microbiological associations.
C. Byington (2002)
Primary early thoracoscopy and reduction in length of hospital stay and additional procedures among children with complicated pneumonia: results of a multicenter retrospective cohort study.
Samir S. Shah (2008)
Costs of treating children with complicated pneumonia: a comparison of primary video-assisted thoracoscopic surgery and chest tube placement.
S. Shah (2010)
Increase in incidence of childhood empyema in West Midlands, UK
J. Rees (1997)
Toracoscopia no tratamento do empiema pleural em pacientes pediátricos
Davi Wen Wei Kang (2008)
Empyema thoracis is still increasing in UK children
D. Spencer (2006)
Impact of the Pneumococcal Conjugate Vaccine on Pneumococcal Parapneumonic Empyema
C. Byington (2006)
Distribution des sérotypes de pneumocoques responsables des pleuropneumopathies de l'enfant en France
H. Bekri (2007)
Therapy of Parapneumonic Effusions in Children: Video-Assisted Thoracoscopic Surgery Versus Conventional Thoracostomy Drainage
B. Kurt (2006)
Comparative analysis of chest tube thoracostomy and video-assisted thoracoscopic surgery in empyema and parapneumonic effusion associated with pneumonia in children.
A. Aziz (2008)
This paper is referenced by
Giant lung cysts following necrotizing pneumonia: Resolution with conservative treatment.
Itai Gross (2019)
Retrospective Study in Children With Necrotizing Pneumonia: Nine Years of Intensive Care Experience
Elena Blanco-Iglesias (2020)
Characteristics of Streptococcus pyogenes Versus Streptococcus pneumoniae Pleural Empyema and Pneumonia With Pleural Effusion in Children
O. Megged (2020)
The health status and insurance affiliation of stateless children in Tak Province, Thailand
Proloy Barua (2020)
Pediatric Pulmonology year in review 2017: Part 3.
C. Ren (2018)
Should Empyema with or without Necrotizing Pneumonia in Children Be Managed Differently
Karine Anastaze Stelle (2017)
Community-acquired pneumonia in children: cell-free plasma sequencing for diagnosis and management☆☆☆★
L. Farnaes (2019)
Predictors of Prolonged Hospitalizations in Pediatric Complicated Pneumonia
O. Breuer (2018)
Predictive value of Thomsen-Friedenreich antigen activation for Streptococcus pneumoniae infection and severity in pediatric lobar pneumonia.
Chia-Jung Chang (2017)
Trends in Pediatric Complicated Pneumonia in an Ontario Local Health Integration Network
Tahereh Haji (2018)
Management of necrotizing pneumonia in children: Time for a patient-oriented approach.
F. D. de Benedictis (2019)
Changes in the incidence and bacterial aetiology of paediatric parapneumonic pleural effusions/empyema in Germany, 2010-2017: a nationwide surveillance study.
J. Liese (2019)
Lobectomy on ECMO as a Life-Saving Procedure following Necrotizing Pneumonia in a Toddler: A Case Study.
Shira Ashkenazi (2018)
Change in Bacterial Causes of Community-Acquired Parapneumonic Effusion and Pleural Empyema in Children 6 Years After 13-Valent Pneumococcal Conjugate Vaccine Implementation.
Fouad Madhi (2018)
Factors Associated With Pneumonia Severity in Children: A Systematic Review.
P. Dean (2018)
NECROTIZING PNEUMONIA CAUSED BY ACINETOBACTER IIWOFI IN A PREVIOUSLY HEALTHY CHILD
shanta carleen magalit (2019)
Necrotizing pneumonia: an emerging problem in children?
I. Masters (2017)
Factores asociados a neumonía complicada Instituto Nacional de Salud del Niño 2016
Yuliana Patricia Catacora Sagredo (2019)
Streptococcus pneumoniae, an unusual cause of early‐onset neonatal sepsis and necrotizing pneumonia
M. A. Apilánez Urquiola (2018)